TrialNature cancer2025

Atezolizumab following definitive chemoradiotherapy in patients with unresectable locally advanced esophageal squamous cell carcinoma - a multicenter phase 2 trial (EPOC1802).

Hideaki Bando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.